Question for May
01, 2002:
Information:
VALIDATION
PROTOCOL FOR HPV IN SITU HYBRIDIZATION
There has been a recent
strong push to incorporate HPV testing into the
diagnostic surgical and cytopathology
laboratory. This is especially true for
biopsies and Pap smears that contain atypical
squamous cells of undetermined significance.
HPV testing by in situ hybridization has many
advantages over hybrid capture or PCR, including the
ability to actually see the infected cells and to
detect ONLY productive infection. In situ HPV
testing is now automated; the attached document
details a validation protocol for HPV using the
BenchMark System of Ventana.
To
view the documentation in Microsoft
Power
Point format click the link below.
The
presentation will take a couple minutes to download
so
please be patient. To advance thru the presentation
simply
left click.